Low-grade astrocytomas: the prognostic value of fibrillary, gemistocytic, and protoplasmic tumor histology

Clinical article

Ranjith Babu M.S.1, Jacob H. Bagley B.S.1, Jong G. Park B.S.1, Allan H. Friedman M.D.1, and Cory Adamson M.D., Ph.D., M.P.H., M.H.Sc.1,2
View More View Less
  • 1 Division of Neurosurgery, Department of Surgery, Duke University Medical Center; and
  • | 2 Neurosurgery Section, Durham VA Medical Center, Durham, North Carolina
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
Print or Print + Online

Object

Low-grade astrocytomas are slow-growing, infiltrative gliomas that over time may progress into more malignant tumors. Various factors have been shown to affect the time to progression and overall survival including age, performance status, tumor size, and the extent of resection. However, more recently it has been suggested that histological subtypes (fibrillary, protoplasmic, and gemistocytic) may impact patient outcome. In this study the authors have performed a large comparative population-based analysis to examine the characteristics and survival of patients with the various subtypes of WHO Grade II astrocytomas.

Methods

Patients diagnosed with fibrillary, protoplasmic, and gemistocytic astrocytomas were identified through the Surveillance, Epidemiology, and End Results (SEER) database. The chi-square test and Student t-test were used to evaluate differences in patient and treatment characteristics between astrocytoma subtypes. Kaplan-Meier analysis was used to assess overall survival, and the log-rank test was used to evaluate the differences between survival curves. Univariate and multivariate analyses were also performed to determine the effect of various patient, tumor, and treatment variables on overall survival.

Results

A total of 500 cases were included in the analysis, consisting of 326 fibrillary (65.2%), 29 protoplasmic (5.8%), and 145 gemistocytic (29%) variants. Gemistocytic astrocytomas presented at a significantly older age than the fibrillary variant (46.8 vs 37.7 years, p < 0.0001), with protoplasmic and fibrillary subtypes having a similar age. Although protoplasmic and fibrillary variants underwent radiotherapy at similar rates, gemistocytic tumors more frequently received radiotherapy (p = 0.0001). Univariate analysis revealed older age, larger tumor size, and the use of radiotherapy to be poor prognostic factors, with resection being associated with improved survival. The gemistocytic subtype (hazard ratio [HR] 1.62 [95% CI 1.27–2.07], p = 0.0001) also resulted in significantly worse survival than fibrillary tumors. Bivariate analyses demonstrated that older age, the use of radiotherapy, and resection significantly influenced median survival. Tumor subtype also affected median survival; patients who harbored gemistocytic tumors experienced less than half the median survival of fibrillary and protoplasmic tumors (38 vs 82 months, p = 0.0003). Multivariate analysis revealed increasing age (HR 1.05 [95% CI 1.04–1.05], p < 0.0001), larger tumor size (HR 1.02 [95% CI 1.01–1.03], p = 0.0002), and the use of resection (HR 0.70 [95% CI 0.52–0.94], p = 0.018) to be independent predictors of survival. Examination of tumor subtype revealed that the gemistocytic variant (HR 1.30 [95% CI 0.98–1.74], p = 0.074) was associated with worse patient survival than fibrillary tumors, although this only approached significance. The protoplasmic subtype did not affect overall survival (p = 0.33).

Conclusions

Gemistocytic tumor histology was associated with worse survival than fibrillary and protoplasmic astrocytomas. As protoplasmic astrocytomas have a survival similar to fibrillary tumors, there may be limited utility to the identification of this rare variant. However, increased attention should be paid to the presence of gemistocytes in low-grade gliomas as this is associated with shorter time to progression, increased malignant transformation, and reduced overall survival.

Abbreviations used in this paper:

GFAP = glial fibrillary acidic protein; HR = hazard ratio; LGA = low-grade astrocytoma; SEER = Surveillance, Epidemiology, and End Results.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $515.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $612.00
  • 1

    al-Sarraj S, & Bridges LR: p53 immunoreactivity in astrocytomas and its relationship to survival. Br J Neurosurg 9:143149, 1995

  • 2

    Avninder S, , Sharma MC, , Deb P, , Mehta VS, , Karak AK, & Mahapatra AK, et al.: Gemistocytic astrocytomas: histomorphology, proliferative potential and genetic alterations—a study of 32 cases. J Neurooncol 78:123127, 2006

    • Search Google Scholar
    • Export Citation
  • 3

    Chaichana KL, , McGirt MJ, , Laterra J, , Olivi A, & Quiñones-Hinojosa A: Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. Clinical article. J Neurosurg 112:1017, 2010

    • Search Google Scholar
    • Export Citation
  • 4

    Chang EF, , Clark A, , Jensen RL, , Bernstein M, , Guha A, & Carrabba G, et al.: Multiinstitutional validation of the University of California at San Francisco Low-Grade Glioma Prognostic Scoring System. Clinical article. J Neurosurg 111:203210, 2009

    • Search Google Scholar
    • Export Citation
  • 5

    Chang EF, , Smith JS, , Chang SM, , Lamborn KR, , Prados MD, & Butowski N, et al.: Preoperative prognostic classification system for hemispheric low-grade gliomas in adults. Clinical article. J Neurosurg 109:817824, 2008

    • Search Google Scholar
    • Export Citation
  • 6

    Chozick BS, , Pezzullo JC, , Epstein MH, & Finch PW: Prognostic implications of p53 overexpression in supratentorial astrocytic tumors. Neurosurgery 35:831838, 1994

    • Search Google Scholar
    • Export Citation
  • 7

    Daniels TB, , Brown PD, , Felten SJ, , Wu W, , Buckner JC, & Arusell RM, et al.: Validation of EORTC prognostic factors for adults with low-grade glioma: a report using intergroup 86-72-51. Int J Radiat Oncol Biol Phys 81:218224, 2011

    • Search Google Scholar
    • Export Citation
  • 8

    Geranmayeh F, , Scheithauer BW, , Spitzer C, , Meyer FB, , Svensson-Engwall AC, & Graeber MB: Microglia in gemistocytic astrocytomas. Neurosurgery 60:159166, 2007

    • Search Google Scholar
    • Export Citation
  • 9

    Hilton DA, , Love S, , Barber R, , Ellison D, & Sandeman DR: Accumulation of p53 and Ki-67 expression do not predict survival in patients with fibrillary astrocytomas or the response of these tumors to radiotherapy. Neurosurgery 42:724729, 1998

    • Search Google Scholar
    • Export Citation
  • 10

    Hoshino T, , Wilson BC, & Ellis WG: Gemistocytic astrocytes in gliomas. An autoradiographic study. J Neuropathol Exp Neurol 34:263281, 1975

    • Search Google Scholar
    • Export Citation
  • 11

    Ishii N, , Tada M, , Hamou MF, , Janzer RC, , Meagher-Villemure K, & Wiestler OD, et al.: Cells with TP53 mutations in low grade astrocytic tumors evolve clonally to malignancy and are an unfavorable prognostic factor. Oncogene 18:58705878, 1999

    • Search Google Scholar
    • Export Citation
  • 12

    Jung TY, , Jung S, , Moon JH, , Kim IY, , Moon KS, & Jang WY: Early prognostic factors related to progression and malignant transformation of low-grade gliomas. Clin Neurol Neurosurg 113:752757, 2011

    • Search Google Scholar
    • Export Citation
  • 13

    Karim AB, , Afra D, , Cornu P, , Bleehan N, , Schraub S, & De Witte O, et al.: Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis. Int J Radiat Oncol Biol Phys 52:316324, 2002

    • Search Google Scholar
    • Export Citation
  • 14

    Kleihues P, , Soylemezoglu F, , Schäuble B, , Scheithauer BW, & Burger PC: Histopathology, classification, and grading of gliomas. Glia 15:211221, 1995

    • Search Google Scholar
    • Export Citation
  • 15

    Kösel S, , Scheithauer BW, & Graeber MB: Genotype-phenotype correlation in gemistocytic astrocytomas. Neurosurgery 48:187194, 2001

  • 16

    Kraus JA, , Bolln C, , Wolf HK, , Neumann J, , Kindermann D, & Fimmers R, et al.: TP53 alterations and clinical outcome in low grade astrocytomas. Genes Chromosomes Cancer 10:143149, 1994

    • Search Google Scholar
    • Export Citation
  • 17

    Krouwer HG, , Davis RL, , Silver P, & Prados M: Gemistocytic astrocytomas: a reappraisal. J Neurosurg 74:399406, 1991

  • 18

    Lind-Landström T, , Habberstad AH, & Torp SH: Proliferative activity and histopathological features in diffuse grade II astrocytomas. APMIS 120:640647, 2012

    • Search Google Scholar
    • Export Citation
  • 19

    Lote K, , Egeland T, , Hager B, , Stenwig B, , Skullerud K, & Berg-Johnsen J, et al.: Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients. J Clin Oncol 15:31293140, 1997

    • Search Google Scholar
    • Export Citation
  • 20

    Malin JL, , Kahn KL, , Adams J, , Kwan L, , Laouri M, & Ganz PA: Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst 94:835844, 2002

    • Search Google Scholar
    • Export Citation
  • 21

    Okamoto Y, , Di Patre PL, , Burkhard C, , Horstmann S, , Jourde B, & Fahey M, et al.: Population-based study on incidence, survival rates, and genetic alterations of low-grade diffuse astrocytomas and oligodendrogliomas. Acta Neuropathol 108:4956, 2004

    • Search Google Scholar
    • Export Citation
  • 22

    Pignatti F, , van den Bent M, , Curran D, , Debruyne C, , Sylvester R, & Therasse P, et al.: Prognostic factors for survival in adult patients with cerebral low-grade glioma. J Clin Oncol 20:20762084, 2002

    • Search Google Scholar
    • Export Citation
  • 23

    Prayson RA, & Estes ML: Protoplasmic astrocytoma. A clinicopathologic study of 16 tumors. Am J Clin Pathol 103:705709, 1995

  • 24

    Reis RM, , Hara A, , Kleihues P, & Ohgaki H: Genetic evidence of the neoplastic nature of gemistocytes in astrocytomas. Acta Neuropathol 102:422425, 2001

    • Search Google Scholar
    • Export Citation
  • 25

    Sanai N, & Berger MS: Glioma extent of resection and its impact on patient outcome. Neurosurgery 62:753764, 2008

  • 26

    Sanai N, & Berger MS: Recent surgical management of gliomas. Adv Exp Med Biol 746:1225, 2012

  • 27

    Sanai N, , Chang S, & Berger MS: Low-grade gliomas in adults. A review. J Neurosurg 115:948965, 2011

  • 28

    Schomas DA, , Laack NN, , Rao RD, , Meyer FB, , Shaw EG, & O'Neill BP, et al.: Intracranial low-grade gliomas in adults: 30-year experience with long-term follow-up at Mayo Clinic. Neuro Oncol 11:437445, 2009

    • Search Google Scholar
    • Export Citation
  • 29

    Smith JS, , Chang EF, , Lamborn KR, , Chang SM, , Prados MD, & Cha S, et al.: Role of extent of resection in the long-term outcome of low-grade hemispheric gliomas. J Clin Oncol 26:13381345, 2008

    • Search Google Scholar
    • Export Citation
  • 30

    Tay KL, , Tsui A, , Phal PM, , Drummond KJ, & Tress BM: MR imaging characteristics of protoplasmic astrocytomas. Neuroradiology 53:405411, 2011

    • Search Google Scholar
    • Export Citation
  • 31

    Tihan T, , Vohra P, , Berger MS, & Keles GE: Definition and diagnostic implications of gemistocytic astrocytomas: a pathological perspective. J Neurooncol 76:175183, 2006

    • Search Google Scholar
    • Export Citation
  • 32

    van den Bent MJ, , Afra D, , de Witte O, , Ben Hassel M, , Schraub S, & Hoang-Xuan K, et al.: Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial. Lancet 366:985990, 2005

    • Search Google Scholar
    • Export Citation
  • 33

    Walker DG, & Kaye AH: Low grade glial neoplasms. J Clin Neurosci 10:113, 2003

  • 34

    Watanabe K, , Peraud A, , Gratas C, , Wakai S, , Kleihues P, & Ohgaki H: p53 and PTEN gene mutations in gemistocytic astrocytomas. Acta Neuropathol 95:559564, 1998

    • Search Google Scholar
    • Export Citation
  • 35

    Watanabe K, , Tachibana O, , Yonekawa Y, , Kleihues P, & Ohgaki H: Role of gemistocytes in astrocytoma progression. Lab Invest 76:277284, 1997

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 1764 471 64
Full Text Views 570 31 0
PDF Downloads 204 24 0
EPUB Downloads 0 0 0